Medicare has proposed revamping its payment rules to get more people into a diabetes prevention plan that helps them eat better, exercise more and maintain a healthier lifestyle. Out of an estimated 16 million Medicare beneficiaries whose excess weight and other risk factors make them eligible, only 3,600 have participated since 2018.
Policies mandating company approval before talking publicly about conditions in hospitals have been a source of conflict over the past year, as physicians, nurses and other health workers have been disciplined for speaking or posting about what they view as dangerous covid-19 safety precautions. The appeals court’s decision could mean that hospitals — and other employers — will need to revise their policies.
The agency is to decide by June 7 whether to greenlight Biogen’s drug aducanumab, despite a near-unanimous rejection of the product by an FDA advisory committee of outside experts in November. Some scientists at the agency have endorsed the drug, though.
Responsible for 34% of the nation’s covid death toll, nursing homes and long-term care facilities get slammed by their investors and are told to change.
A misguided federal program called the Unapproved Drugs Initiative, which put the FDA’s stamp of approval on old drugs, led to higher prices. It’s scrapped. So now what?
Many state Medicaid programs pay out-of-state providers much less than in-state facilities, often making it hard for families with medically complex children to get the care they seek.
A Texas federal judge, who previously ruled the Affordable Care Act unconstitutional, has signaled his openness to ending the law’s popular coverage requirement for preventive services.
One group of maternal health experts in 2016 urged doctors to give all women heparin shots after C-sections, barring specific medical risks for individual patients. But many physicians disagree, questioning whether wide use of the drug is effective, worth the cost and safe, since it carries the risk of bleeding.
The measures would impose taxes on increases in the price of drugs that don’t reflect improved clinical value and set the rates paid by state-run and commercial health plans to a benchmark based on prices in Canada.
The wealthy corporation that owns Chicago’s Mercy Hospital says it must close the hospital because it’s losing money. A government board says no. The corporation still has the upper hand.